These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16775339)

  • 21. Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.
    Bongertz V; Costa CI; Veloso VG; Grinsztejn B; João Filho EC; Calvet G; Pilotto JH; Guimarães ML; Morgado MG
    Scand J Immunol; 2001 Mar; 53(3):302-9. PubMed ID: 11251889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternofetal transmission of human immunodeficiency virus-1: the role of antibodies to the V3 primary neutralizing domain.
    Rubinstein A; Goldstein H; Calvelli T; Devash Y; Rubinstein R; Soeiro R; Lyman W
    Pediatr Res; 1993 Jan; 33(1 Suppl):S76-8; discussion S78-9. PubMed ID: 8433879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.
    Watkins BA; Reitz MS; Wilson CA; Aldrich K; Davis AE; Robert-Guroff M
    J Virol; 1993 Dec; 67(12):7493-500. PubMed ID: 7693973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts.
    Frater AJ; Edwards CT; McCarthy N; Fox J; Brown H; Milicic A; Mackie N; Pillay T; Drijfhout JW; Dustan S; Clarke JR; Holmes EC; Zhang HT; Pfafferott K; Goulder PJ; McClure MO; Weber J; Phillips RE; Fidler S
    J Virol; 2006 Jul; 80(14):7226-34. PubMed ID: 16809328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.
    Wilson CC; Brown RC; Korber BT; Wilkes BM; Ruhl DJ; Sakamoto D; Kunstman K; Luzuriaga K; Hanson IC; Widmayer SM; Wiznia A; Clapp S; Ammann AJ; Koup RA; Wolinsky SM; Walker BD
    J Virol; 1999 May; 73(5):3975-85. PubMed ID: 10196293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.
    Lathey JL; Tsou J; Brinker K; Hsia K; Meyer WA; Spector SA
    J Infect Dis; 1999 Aug; 180(2):344-50. PubMed ID: 10395848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.
    deCamp A; Hraber P; Bailer RT; Seaman MS; Ochsenbauer C; Kappes J; Gottardo R; Edlefsen P; Self S; Tang H; Greene K; Gao H; Daniell X; Sarzotti-Kelsoe M; Gorny MK; Zolla-Pazner S; LaBranche CC; Mascola JR; Korber BT; Montefiori DC
    J Virol; 2014 Mar; 88(5):2489-507. PubMed ID: 24352443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.
    Malherbe DC; Pissani F; Sather DN; Guo B; Pandey S; Sutton WF; Stuart AB; Robins H; Park B; Krebs SJ; Schuman JT; Kalams S; Hessell AJ; Haigwood NL
    J Virol; 2014 Nov; 88(22):12949-67. PubMed ID: 25210191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.
    Dieltjens T; Heyndrickx L; Willems B; Gray E; Van Nieuwenhove L; Grupping K; Vanham G; Janssens W
    Retrovirology; 2009 Dec; 6():113. PubMed ID: 20003438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies.
    Arendrup M; Nielsen C; Hansen JE; Pedersen C; Mathiesen L; Nielsen JO
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):303-7. PubMed ID: 1740756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation
    Fauteux-Daniel S; Larouche A; Calderon V; Boulais J; Béland C; Ransy DG; Boucher M; Lamarre V; Lapointe N; Boucoiran I; Le Campion A; Soudeyns H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections.
    Fenyö EM; Putkonen P
    Immunol Lett; 1996 Jun; 51(1-2):95-9. PubMed ID: 8811351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Shaffer N; Roongpisuthipong A; Siriwasin W; Chotpitayasunondh T; Chearskul S; Young NL; Parekh B; Mock PA; Bhadrakom C; Chinayon P; Kalish ML; Phillips SK; Granade TC; Subbarao S; Weniger BG; Mastro TD
    J Infect Dis; 1999 Mar; 179(3):590-9. PubMed ID: 9952365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant.
    Wu X; Parast AB; Richardson BA; Nduati R; John-Stewart G; Mbori-Ngacha D; Rainwater SM; Overbaugh J
    J Virol; 2006 Jan; 80(2):835-44. PubMed ID: 16378985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers.
    Mahalanabis M; Jayaraman P; Miura T; Pereyra F; Chester EM; Richardson B; Walker B; Haigwood NL
    J Virol; 2009 Jan; 83(2):662-72. PubMed ID: 18987151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal assessment of autologous neutralizing antibodies in children perinatally infected with human immunodeficiency virus type 1.
    Geffin R; Hutto C; Andrew C; Scott GB
    Virology; 2003 Jun; 310(2):207-15. PubMed ID: 12781708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous neutralizing antibody to human immunodeficiency virus-1 and replication-competent virus recovered from CD4+ T-cell reservoirs in pediatric HIV-1-infected patients on HAART.
    Ching N; Nielsen-Saines KA; Deville JG; Wei LS; Garratty E; Bryson YJ
    AIDS Res Hum Retroviruses; 2010 May; 26(5):585-91. PubMed ID: 20455762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1.
    Barin F; Jourdain G; Brunet S; Ngo-Giang-Huong N; Weerawatgoompa S; Karnchanamayul W; Ariyadej S; Hansudewechakul R; Achalapong J; Yuthavisuthi P; Ngampiyaskul C; Bhakeecheep S; Hemwutthiphan C; Lallemant M;
    J Infect Dis; 2006 Jun; 193(11):1504-11. PubMed ID: 16652277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of immunity in maternal-infant HIV-1 transmission.
    Jansson M; Orlandi P; Scarlatti G; Moschese V; Romiti ML; Cancrini C; Mancia L; Livadiotti S; Castelli-Gattinara G; Rossi P; Halapi E
    Acta Paediatr Suppl; 1997 Jun; 421():39-45. PubMed ID: 9240856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.